Stacey Bean, MD
Family Medicine · Chapel Hill, NCNPI 1699700674
Payments from drug & device makers
Across 122 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$431
- Lilly USA, LLC$394
- Pfizer$209
- Novo Nordisk$192
- Exact Sciences$100
- Bausch Health US, LLC$86
- plus $732 from 23 others
What the payments were for
- Food & beverage$2,144100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $431 |
| Lilly USA, LLC | 24 | $394 |
| Pfizer | 11 | $209 |
| Novo Nordisk | 11 | $192 |
| Exact Sciences | 5 | $100 |
| Bausch Health US, LLC | 5 | $86 |
| Boehringer Ingelheim | 3 | $64 |
| GSK | 4 | $62 |
| Gilead | 3 | $58 |
| AstraZeneca | 4 | $57 |
| Amgen(2 entities) | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Mayne Pharma Commercial LLC | 3 | $47 |
| Astellas Pharma US Inc | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Abbott | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Clarus Therapeutics Inc. | 1 | $16 |
| Lupin Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Irhythm Technologies, Inc. | 1 | $11 |
How this compares
$2,144 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 36 | $509 |
| Rosuvastatin Calcium | 19 | $266 |
| Clonazepam | 12 | $174 |
| Metformin Hcl ErMetformin Hcl | 13 | $108 |
| Losartan Potassium | 13 | $99 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chapel Hill
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.